LMF Acquisition Net Income From Continuing Ops Over Time
| ICU Stock | USD 2.50 0.04 1.57% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out LMF Acquisition Performance and LMF Acquisition Correlation. LMF |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LMF Acquisition. If investors know LMF will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LMF Acquisition listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.19) | Return On Assets (3.08) |
The market value of LMF Acquisition Oppo is measured differently than its book value, which is the value of LMF that is recorded on the company's balance sheet. Investors also form their own opinion of LMF Acquisition's value that differs from its market value or its book value, called intrinsic value, which is LMF Acquisition's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LMF Acquisition's market value can be influenced by many factors that don't directly affect LMF Acquisition's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LMF Acquisition's value and its price as these two are different measures arrived at by different means. Investors typically determine if LMF Acquisition is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LMF Acquisition's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income From Continuing Ops Analysis
Compare LMF Acquisition Oppo and related stocks such as ZyVersa Therapeutics, Sonnet Biotherapeutics, and Revelation Biosciences Net Income From Continuing Ops Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZVSA | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (8.1 M) | (14 M) | (89.6 M) | (85.1 M) |
| SONN | (5.3 M) | (5.3 M) | (5.3 M) | (5.7 M) | (5.7 M) | (14.5 M) | (7.2 M) | (7.2 M) | (7.2 M) | (17.4 M) | (25 M) | (29.7 M) | (18.8 M) | (17.4 M) | (18.3 M) |
| REVB | 4.5 M | 4.5 M | 4.5 M | 4.5 M | 4.5 M | 6.2 M | 8.8 M | 16.3 M | 27.6 M | 31.7 M | (12 M) | (12 M) | (10.8 M) | 875.1 K | 831.3 K |
| QNRX | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (2.1 M) | (21.5 M) | (9.4 M) | (8.6 M) | (9.1 M) |
| ALLR | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (5.1 M) | (26.6 M) | (16.1 M) | (13 M) | (13.7 M) |
| VRAX | (739.5 K) | (739.5 K) | (739.5 K) | (739.5 K) | (739.5 K) | (739.5 K) | (739.5 K) | (739.5 K) | (739.5 K) | (739.5 K) | (672.9 K) | (1.7 M) | (5.5 M) | (6.7 M) | (6.4 M) |
| BDRX | (9.1 M) | (9.1 M) | (9.1 M) | (9.1 M) | (9.1 M) | (9.1 M) | (9.1 M) | (9.1 M) | (9.1 M) | (9.1 M) | (22.2 M) | (5.5 M) | (7.7 M) | (7.1 M) | (7.4 M) |
| PALI | (10.3 M) | (10.3 M) | (10.3 M) | (10.3 M) | (10.3 M) | (10.3 M) | (10.3 M) | (10.3 M) | (10.3 M) | (10.3 M) | (10.3 M) | (26.6 M) | (14.3 M) | (12.3 M) | (12.9 M) |
| UNCY | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.3 M) | (10 M) | (18.1 M) | (28.1 M) | (26.7 M) |
| IMMX | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (1.1 M) | (24.4 M) | (8.2 M) | (14.2 M) | (15 M) |
LMF Acquisition Oppo and related stocks such as ZyVersa Therapeutics, Sonnet Biotherapeutics, and Revelation Biosciences Net Income From Continuing Ops description
My Equities
My Current Equities and Potential Positions
| LMF Acquisition Opportunities | ICU |
| Classification | Medical Equipment |
| Location | Colorado; U.S.A |
| Exchange | NASDAQ Exchange |
USD 2.5
Additional Tools for LMF Stock Analysis
When running LMF Acquisition's price analysis, check to measure LMF Acquisition's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LMF Acquisition is operating at the current time. Most of LMF Acquisition's value examination focuses on studying past and present price action to predict the probability of LMF Acquisition's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LMF Acquisition's price. Additionally, you may evaluate how the addition of LMF Acquisition to your portfolios can decrease your overall portfolio volatility.